, Tracking Stock Market Picks
Enter Symbol:
Rating: ABMD
Outperform $34

Abiomed, Inc. (NASDAQ: ABMD) rated to Outperform with price target $34 by Leerink Swann

Monday,  Mar 24, 2014  8:25 AM ET by Betsy O'Brien Harrison

Leerink Swann rated
Abiomed, Inc. (NASDAQ: ABMD) to Outperform with price target $34.

ACCO Brands Corporation is a world leader in branded office products. Its industry-leading brands include Swingline, Kensington, Wilson Jones, Quartet, GBC, and Day-Timer, among others. Under the GBC brand, the Company is also a leader in the professional printing market.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy